Pictet Asset Management
JBIO

Pictet Asset Management’s Jade Biosciences JBIO Stock Holding History

Pictet Asset Management’s Portfolio JBIO Stock Details JBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$16.3M Buy
+733,768
New +$15.3M 0.02% 587

Other funds holding JBIO

Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
HP
HealthInvest Partners Stockholm, Sweden $372M AUM 59.89% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
DAM
Deltec Asset Management New York $677M AUM 31.67% 1-Year Est. Return
PFSRSONJ
Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return
SO
STRS Ohio Columbus, Ohio $26.7B AUM 43.32% 1-Year Est. Return
EWA
EverSource Wealth Advisors Birmingham, Alabama $2.97B AUM 28.74% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return
VCM
Versant Capital Management Phoenix, Arizona $1.12B AUM 34.21% 1-Year Est. Return
S
SignatureFD Atlanta, Georgia $7.49B AUM 24.82% 1-Year Est. Return

Pictet Asset Management's JBIO Position: Q2 2026 in Review

Pictet Asset Management opened a new position in Jade Biosciences (JBIO) in Q2 2026: 733,768 shares worth $16.3M. The stake represents 0.02% of the portfolio and ranks #587 among its holdings.

25 funds tracked by Wall St. Rank hold JBIO as of Q2 2026.

  • Pictet Asset Management held 733,768 shares of Jade Biosciences worth $16.3M as of Q2 2026.
  • Jade Biosciences was a new Pictet Asset Management position in Q2 2026.
  • Jade Biosciences made up 0.02% of Pictet Asset Management's portfolio in Q2 2026, its #587 holding.
  • 25 funds tracked by Wall St. Rank held Jade Biosciences as of Q2 2026.

Based on Pictet Asset Management's 13F filing for Q2 2026, filed 30 Jul 2026.